Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,217 | 336 | 99.8% |
| Education | $11.90 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $915.15 | 69 | $0 (2024) |
| ABBVIE INC. | $902.00 | 58 | $0 (2024) |
| Lilly USA, LLC | $439.23 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $358.83 | 22 | $0 (2024) |
| Amgen Inc. | $291.24 | 16 | $0 (2022) |
| Merck Sharp & Dohme LLC | $258.86 | 21 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $199.20 | 12 | $0 (2024) |
| PFIZER INC. | $185.04 | 15 | $0 (2024) |
| Abbott Laboratories | $150.25 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $141.50 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,031 | 58 | Novo Nordisk Inc ($223.87) |
| 2023 | $883.31 | 52 | AbbVie Inc. ($302.66) |
| 2022 | $1,025 | 69 | ABBVIE INC. ($376.57) |
| 2021 | $205.66 | 12 | AbbVie Inc. ($68.68) |
| 2020 | $40.91 | 3 | Amarin Pharma Inc. ($15.14) |
| 2019 | $639.28 | 40 | Novo Nordisk Inc ($149.73) |
| 2018 | $562.10 | 41 | Merck Sharp & Dohme Corporation ($116.93) |
| 2017 | $841.94 | 62 | Novo Nordisk Inc ($154.90) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.84 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PAIN | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Gastroenterology | ||||||
| 08/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 187 | 325 | $63,219 | $14,743 |
| 2022 | 5 | 203 | 306 | $54,783 | $14,577 |
| 2021 | 5 | 178 | 270 | $47,067 | $20,481 |
| 2020 | 6 | 162 | 244 | $40,381 | $14,119 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 205 | $42,845 | $10,087 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 67 | $9,514 | $2,455 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $7,380 | $1,784 | 24.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 12 | 12 | $3,480 | $416.16 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 183 | $38,247 | $9,701 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 69 | $9,798 | $2,539 | 25.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $5,040 | $1,226 | 24.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $1,353 | $772.75 | 57.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $345.00 | $338.10 | 98.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 156 | $32,604 | $12,726 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $5,580 | $3,890 | 69.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 46 | $6,532 | $2,518 | 38.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $1,845 | $996.45 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $506.00 | $349.94 | 69.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 135 | $28,215 | $8,768 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 22 | 22 | $3,960 | $2,424 | 61.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 36 | $5,112 | $1,648 | 32.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 13 | 13 | $1,599 | $792.74 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 17 | $391.00 | $269.47 | 68.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 21 | $1,104 | $215.92 | 19.6% |
About Dr. Young Cho, M.D
Dr. Young Cho, M.D is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154359891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Young Cho, M.D has received a total of $5,229 in payments from pharmaceutical and medical device companies, with $1,031 received in 2024. These payments were reported across 337 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,217).
As a Medicare-enrolled provider, Cho has provided services to 730 Medicare beneficiaries, totaling 1,145 services with total Medicare billing of $63,919. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 06/29/2006
- Last Updated 01/28/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154359891
Products in Payments
- UBRELVY (Drug) $516.71
- Ozempic (Drug) $333.30
- MOUNJARO (Drug) $228.82
- VRAYLAR (Drug) $218.83
- XIFAXAN (Drug) $197.09
- Rybelsus (Drug) $184.01
- AIRSUPRA (Drug) $160.99
- Aimovig (Biological) $142.67
- JARDIANCE (Drug) $140.87
- Wegovy (Drug) $136.78
- QULIPTA (Drug) $117.98
- TRULICITY (Drug) $115.12
- Victoza (Drug) $110.70
- CHANTIX (Drug) $108.08
- FARXIGA (Drug) $106.63
- Prolia (Biological) $103.13
- SIVEXTRO (Drug) $84.88
- JANUVIA (Drug) $80.81
- VYVANSE (Drug) $76.81
- FREESTYLE LIBRE 3 (Device) $72.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Constance Irick, M.d, M.D
Family Medicine — Payments: $21,543
Travis Keller, Md, MD
Family Medicine — Payments: $13,363
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Kathryn Chartrand, Do, DO
Family Medicine — Payments: $4,596